ロード中...
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced
BACKGROUND: The global pandemic COVID-19 caused by the new coronavirus SARS-CoV-2 has already caused about 1.4 million deaths, and to date, there are no effective or direct antiviral vaccines. Some vaccines are in the last stages of testing. Overall mortality rates vary between countries, for exampl...
保存先:
| 出版年: | Egypt Liver Journal |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7838235/ https://ncbi.nlm.nih.gov/pubmed/34777865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43066-021-00082-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|